Desq Long
Sign in

Company

Opus Genetics, Inc.

IRD · CIK 0001228627

SEC FORM 4
$450,980.55

Opus Genetics, Inc. (IRD)

Acquisition (code M) of 392,157 shares at $1.15 per share.

Reporting Person Magrath George · Officer Title Chief Executive Officer · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001140361-26-036347 · filed 2026-09-11 · View filing →

SEC FORM 4
$450,979.77

Opus Genetics, Inc. (IRD)

Disposition (code F) of 75,541 shares at $5.97 per share.

Reporting Person Magrath George · Officer Title Chief Executive Officer · Transaction Code F

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001140361-26-036347 · filed 2026-09-11 · View filing →

SEC FORM 4
$901,961.10

Opus Genetics, Inc. (IRD)

Acquisition (code M) of 784,314 shares at $1.15 per share.

Reporting Person Gallagher Cam · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001140361-26-035913 · filed 2026-09-08 · View filing →

SEC FORM 4
$127,212.40

Opus Genetics, Inc. (IRD)

Sale of 28,000 shares at $4.5433 per share.

Reporting Person Gagnon Robert E. · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001140361-26-035912 · filed 2026-09-08 · View filing →